MBS650493 | Fractalkine, Recombinant, Human, (CX3CL1)

Fractalkine, Recombinant, Human, (CX3CL1) | MBS650493 | MyBiosource

Product Short Name: [Fractalkine,]

Product Name Synonyme: N/A

Other Names: [fractalkine; Fractalkine; fractalkine; OTTHUMP00000164674; C-X3-C motif chemokine 1; small-inducible cytokine D1; CX3C membrane-anchored chemokine; small inducible cytokine subfamily D (Cys-X3-Cys), member-1; small inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, neurotactin); chemokine (C-X3-C motif) ligand 1; C-X3-C motif chemokine 1; CX3C membrane-anchored chemokine; Neurotactin; Small-inducible cytokine D1]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [CX3CL1; CX3CL1; NTN; NTT; CXC3; CXC3C; SCYD1; ABCD-3; C3Xkine; fractalkine; neurotactin; FKN; NTT; SCYD1]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: E Coli

Reactivity: N/A

Specificity: N/A

Purity: Highly Purified
>97% by SDS-PAGE and HPLC analyses.

Form: Supplied as a lyophilized powder in PBS, pH 7.4. Reconstitute in sterile ddH2O or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1mg/ml.

Concentration: N/A

Storage Stability: Lyophilized powder may be stored at -20 degree C. Reconstitute with distilled water, containing 0.1% BSA. Aliquot and store at -20 degree C. Reconstituted product is stable for 6 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Tested Application: N/A